PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy

Title
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
Authors
Keywords
Driver mutation, Immunotherapy, PD-L1, Pulmonary lymphoepithelioma-like carcinoma, Lung cancer, EGFR, KRAS
Journal
LUNG CANCER
Volume 88, Issue 3, Pages 254-259
Publisher
Elsevier BV
Online
2015-04-08
DOI
10.1016/j.lungcan.2015.03.017

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started